Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Chronic lymphocytic leukemia: A brief review
    John C. Krauss, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 42-48;

    CLL, the most common type of leukemia, is often discovered incidentally when a routine complete blood count is performed. This paper reviews the pathology, diagnosis, and treatment of CLL.

  • You have access
    In response: A proper role for organized medicine (May 1997) Editorial
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 50;
  • You have access
    Protoivpump inhibitors for gastric acid-related disease
    Thomas G. Franko, MS and Joel E. Richter, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 27-34;

    Proton-pump inhibitors are the most effective drugs for suppressing gastric acid production. Concerns over potential ill effects of hypergastrinemia have proved unfounded.

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 8;
  • You have access
    A 52-year-old woman with skin lesions and liver function abnormalities
    Hamed Daw, MD and J. Harry Isaacson, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 520-522;

    The patient presents to her doctor with a pruritic rash of 6 weeks’ duration. What is the diagnosis and treatment?

  • You have access
    The uncertain role of immunosuppressive agents in Sjögren’s syndrome
    Garifallia Linardaki, MD and H.M. Moutsopoulos, MD, FRCP
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 523-526;

    Although Sjögren’s syndrome is an autoimmune disorder, immunosuppressive agents have yielded disappointing results in clinical trials.

  • You have access
    Medical McCarthyism: Medicare, teaching hospitals, and charges of health care fraud
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 517-519;

    Real fraud cannot be tolerated, but spurious fraud charges are equally intolerable.

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 508;
  • You have access
    Homocysteine: Update on a new risk factor
    Raj S. Ballal, MD, Donald W. Jacobsen, PHD and Killian Robinson, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 543-549;

    A high fasting plasma homocysteine level is an independent risk factor for atherosclerosis and venous thrombosis.

  • You have access
    Index to Volume 64
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 555-558;

Pages

  • Previous
  • Next
  • 1
  • …
  • 444
  • 445
  • 446
  • 447
  • 448
  • 449
  • 450
  • 451
  • 452
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire